vs

Side-by-side financial comparison of Galaxy Digital Inc. (GLXY) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

Galaxy Digital Inc. is the larger business by last-quarter revenue ($10.4B vs $5.5B, roughly 1.9× TENET HEALTHCARE CORP). TENET HEALTHCARE CORP runs the higher net margin — 11.7% vs -4.6%, a 16.3% gap on every dollar of revenue. TENET HEALTHCARE CORP produced more free cash flow last quarter ($367.0M vs $-1.6B).

Galaxy Digital Inc. is a digital assets and blockchain-focused financial services firm headquartered in New York City. Founded by Michael Novogratz in 2018, the company offers asset management, trading, investment banking, and digital infrastructure services—including data center and high-performance computing operations—to institutional clients in the crypto and broader digital economy. It is listed on Nasdaq under the ticker GLXY.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

GLXY vs THC — Head-to-Head

Bigger by revenue
GLXY
GLXY
1.9× larger
GLXY
$10.4B
$5.5B
THC
Higher net margin
THC
THC
16.3% more per $
THC
11.7%
-4.6%
GLXY
More free cash flow
THC
THC
$2.0B more FCF
THC
$367.0M
$-1.6B
GLXY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GLXY
GLXY
THC
THC
Revenue
$10.4B
$5.5B
Net Profit
$-481.7M
$644.0M
Gross Margin
Operating Margin
-5.4%
15.4%
Net Margin
-4.6%
11.7%
Revenue YoY
9.0%
Net Profit YoY
12.6%
EPS (diluted)
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GLXY
GLXY
THC
THC
Q4 25
$10.4B
$5.5B
Q3 25
$28.4B
$5.3B
Q2 25
$8.7B
$5.3B
Q1 25
$0
$5.2B
Q4 24
$5.1B
Q3 24
$8.5B
$5.1B
Q2 24
$8.9B
$5.1B
Q1 24
$0
$5.4B
Net Profit
GLXY
GLXY
THC
THC
Q4 25
$-481.7M
$644.0M
Q3 25
$505.1M
$579.0M
Q2 25
$30.7M
$522.0M
Q1 25
$0
$622.0M
Q4 24
$572.0M
Q3 24
$-33.3M
$681.0M
Q2 24
$-125.6M
$477.0M
Q1 24
$-1.0K
$2.3B
Operating Margin
GLXY
GLXY
THC
THC
Q4 25
-5.4%
15.4%
Q3 25
1.9%
16.8%
Q2 25
0.5%
15.6%
Q1 25
18.1%
Q4 24
16.2%
Q3 24
-0.5%
21.3%
Q2 24
-1.6%
14.9%
Q1 24
61.2%
Net Margin
GLXY
GLXY
THC
THC
Q4 25
-4.6%
11.7%
Q3 25
1.8%
10.9%
Q2 25
0.4%
9.9%
Q1 25
11.9%
Q4 24
11.3%
Q3 24
-0.4%
13.3%
Q2 24
-1.4%
9.3%
Q1 24
43.5%
EPS (diluted)
GLXY
GLXY
THC
THC
Q4 25
$4.22
Q3 25
$3.86
Q2 25
$3.14
Q1 25
$4.27
Q4 24
$3.79
Q3 24
$4.89
Q2 24
$2.64
Q1 24
$21.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GLXY
GLXY
THC
THC
Cash + ST InvestmentsLiquidity on hand
$2.0B
$2.9B
Total DebtLower is stronger
$13.1B
Stockholders' EquityBook value
$2.0B
$4.2B
Total Assets
$11.3B
$29.7B
Debt / EquityLower = less leverage
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GLXY
GLXY
THC
THC
Q4 25
$2.0B
$2.9B
Q3 25
$2.0B
$3.0B
Q2 25
$1.4B
$2.6B
Q1 25
$1.0K
$3.0B
Q4 24
$3.0B
Q3 24
$4.1B
Q2 24
$2.9B
Q1 24
$2.5B
Total Debt
GLXY
GLXY
THC
THC
Q4 25
$13.1B
Q3 25
$13.1B
Q2 25
$13.1B
Q1 25
$13.1B
Q4 24
$13.1B
Q3 24
$12.8B
Q2 24
$12.8B
Q1 24
$12.8B
Stockholders' Equity
GLXY
GLXY
THC
THC
Q4 25
$2.0B
$4.2B
Q3 25
$1.8B
$4.0B
Q2 25
$1.5B
$3.7B
Q1 25
$1.0K
$4.2B
Q4 24
$4.2B
Q3 24
$2.1B
$3.8B
Q2 24
$2.1B
$3.5B
Q1 24
$2.0K
$3.5B
Total Assets
GLXY
GLXY
THC
THC
Q4 25
$11.3B
$29.7B
Q3 25
$11.5B
$29.4B
Q2 25
$9.1B
$28.7B
Q1 25
$1.0K
$29.2B
Q4 24
$28.9B
Q3 24
$29.4B
Q2 24
$29.3B
Q1 24
$28.9B
Debt / Equity
GLXY
GLXY
THC
THC
Q4 25
3.10×
Q3 25
3.26×
Q2 25
3.49×
Q1 25
3.13×
Q4 24
3.14×
Q3 24
3.33×
Q2 24
3.67×
Q1 24
3.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GLXY
GLXY
THC
THC
Operating Cash FlowLast quarter
$-1.1B
$731.0M
Free Cash FlowOCF − Capex
$-1.6B
$367.0M
FCF MarginFCF / Revenue
-15.7%
6.6%
Capex IntensityCapex / Revenue
5.4%
6.6%
Cash ConversionOCF / Net Profit
1.14×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GLXY
GLXY
THC
THC
Q4 25
$-1.1B
$731.0M
Q3 25
$427.7M
$1.1B
Q2 25
$329.3M
$936.0M
Q1 25
$0
$815.0M
Q4 24
$-331.0M
Q3 24
$1.0B
Q2 24
$747.0M
Q1 24
$-1.0K
$586.0M
Free Cash Flow
GLXY
GLXY
THC
THC
Q4 25
$-1.6B
$367.0M
Q3 25
$189.6M
$778.0M
Q2 25
$-67.2M
$743.0M
Q1 25
$642.0M
Q4 24
$-661.0M
Q3 24
$829.0M
Q2 24
$602.0M
Q1 24
$346.0M
FCF Margin
GLXY
GLXY
THC
THC
Q4 25
-15.7%
6.6%
Q3 25
0.7%
14.7%
Q2 25
-0.8%
14.1%
Q1 25
12.3%
Q4 24
-13.0%
Q3 24
16.2%
Q2 24
11.8%
Q1 24
6.4%
Capex Intensity
GLXY
GLXY
THC
THC
Q4 25
5.4%
6.6%
Q3 25
0.8%
5.3%
Q2 25
4.6%
3.7%
Q1 25
3.3%
Q4 24
6.5%
Q3 24
4.2%
Q2 24
2.8%
Q1 24
4.5%
Cash Conversion
GLXY
GLXY
THC
THC
Q4 25
1.14×
Q3 25
0.85×
1.83×
Q2 25
10.73×
1.79×
Q1 25
1.31×
Q4 24
-0.58×
Q3 24
1.53×
Q2 24
1.57×
Q1 24
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GLXY
GLXY

Digital Assets Sales$10.2B99%
Blockchain Rewards$57.0M1%
Fee$27.4M0%
Blockchain Rewards From Non Customers$1.7M0%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons